Breast cancer

The Future of Breast Cancer Screening: Image-Based Risk Powered by AI

Redefining Cancer Care: Lunit’s CEO on the Future of AI-Driven Detection

Volpara Earns ACR Learning Network Vendor Partner Designation

Real-World Insights into AI-Assisted Breast Cancer Detection

Volpara, a Lunit Company, Secures U.S. Defense Health Agency Contract to Modernize Mammography Services

Volpara Health Surpasses 300 Peer-Reviewed Papers

Join us for a briefing for the Find It Early Act

New insights into high-risk MRI screening re-attendance

Turning the Tide on Breast Cancer Inequities in New Zealand: A Call to Action

Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care